Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 238

1.
2.

National lipid association recommendations for patient-centered management of dyslipidemia: part 1-full report.

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV.

J Clin Lipidol. 2015 Mar-Apr;9(2):129-69. doi: 10.1016/j.jacl.2015.02.003. Epub 2015 Apr 7.

PMID:
25911072
3.

HIV cascade monitoring and simple modelling reveals potential for reductions in HIV incidence.

Kelly SL, Wilson DP.

J Acquir Immune Defic Syndr. 2015 Apr 15. [Epub ahead of print]

PMID:
25886932
4.

Inferring HIV incidence from case surveillance with CD4+ cell counts.

Jansson J, Kerr CC, Mallitt KA, Wu J, Gray RT, Wilson DP.

AIDS. 2015 Apr 13. [Epub ahead of print]

PMID:
25870983
5.

Control of trachoma in australia: a model based evaluation of current interventions.

Shattock AJ, Gambhir M, Taylor HR, Cowling CS, Kaldor JM, Wilson DP.

PLoS Negl Trop Dis. 2015 Apr 10;9(4):e0003474. doi: 10.1371/journal.pntd.0003474. eCollection 2015 Apr.

6.

GBD 2013 and HIV incidence in high income countries.

Supervie V, Archibald CP, Costagliola D, Delpech V, Hall HI, Lot F, van Sighem A, Wilson DP.

Lancet. 2015 Mar 28;385(9974):1177. doi: 10.1016/S0140-6736(15)60626-2. No abstract available.

PMID:
25845784
7.

Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization.

Kerr CC, Stuart RM, Gray RT, Shattock A, Fraser N, Benedikt C, Haacker M, Berdnikov M, Mahmood AM, Jaber SA, Gorgens M, Wilson DP.

J Acquir Immune Defic Syndr. 2015 Mar 23. [Epub ahead of print]

PMID:
25803164
8.

The cost-effectiveness of harm reduction.

Wilson DP, Donald B, Shattock AJ, Wilson D, Fraser-Hurt N.

Int J Drug Policy. 2015 Feb;26 Suppl 1:S5-11. doi: 10.1016/j.drugpo.2014.11.007. Epub 2014 Dec 1.

9.

Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice.

Fraser N, Kerr CC, Harouna Z, Alhousseini Z, Cheikh N, Gray R, Shattock A, Wilson DP, Haacker M, Shubber Z, Masaki E, Karamoko D, Görgens M.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S213-20. doi: 10.1097/QAI.0000000000000456.

PMID:
25723987
10.

Genetics of familial hypercholesterolemia.

Brautbar A, Leary E, Rasmussen K, Wilson DP, Steiner RD, Virani S.

Curr Atheroscler Rep. 2015 Apr;17(4):491. doi: 10.1007/s11883-015-0491-z.

PMID:
25712136
11.

Pediatric dyslipidemia: recommendations for clinical management.

Wilson DP, McNeal C, Blackett P.

South Med J. 2015 Jan;108(1):7-14. doi: 10.14423/SMJ.0000000000000219.

PMID:
25580750
12.

A new approach to estimating trends in chlamydia incidence.

Ali H, Cameron E, Drovandi CC, McCaw JM, Guy RJ, Middleton M, El-Hayek C, Hocking JS, Kaldor JM, Donovan B, Wilson DP; on behalf of the Australian chlamydia incidence estimation group.

Sex Transm Infect. 2015 Jan 6. pii: sextrans-2014-051631. doi: 10.1136/sextrans-2014-051631. [Epub ahead of print]

PMID:
25564675
13.

Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1.

Ahmad Z, Wilson DP.

J Clin Lipidol. 2014 Nov-Dec;8(6):635-9. doi: 10.1016/j.jacl.2014.08.010. Epub 2014 Sep 9.

PMID:
25499947
14.

Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis.

Pham QD, Wilson DP, Law MG, Kelleher AD, Zhang L.

AIDS. 2014 Nov 28;28(18):2751-62. doi: 10.1097/QAD.0000000000000494.

PMID:
25493601
15.

Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey.

Mouton JP, Mehta U, Parrish AG, Wilson DP, Stewart A, Njuguna CW, Kramer N, Maartens G, Blockman M, Cohen K.

Br J Clin Pharmacol. 2014 Dec 5. doi: 10.1111/bcp.12567. [Epub ahead of print]

PMID:
25475751
16.

Feasible HCV targets in Egypt.

Jansson J, Wilson DP.

Lancet Glob Health. 2014 Dec;2(12):e687. doi: 10.1016/S2214-109X(14)70323-7. No abstract available.

17.

Embracing different approaches to estimating HIV incidence, prevalence and mortality.

Hallett TB, Zaba B, Stover J, Brown T, Slaymaker E, Gregson S, Wilson DP, Case KK; UNAIDS Reference Group on Estimates, Modelling and Projections.

AIDS. 2014 Nov;28 Suppl 4:S523-32. doi: 10.1097/QAD.0000000000000488.

18.

National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV.

J Clin Lipidol. 2014 Sep-Oct;8(5):473-88. doi: 10.1016/j.jacl.2014.07.007. Epub 2014 Jul 15.

19.

Men who have sex with men in southern Vietnam report high levels of substance use and sexual risk behaviours but underutilise HIV testing services: a cross-sectional study.

Pham QD, Nguyen TV, Nguyen PD, Le SH, Tran AT, Nguyen LT, Wilson DP, Zhang L.

Sex Transm Infect. 2015 May;91(3):178-82. doi: 10.1136/sextrans-2014-051574. Epub 2014 Sep 2.

PMID:
25182158
20.

Impact of male circumcision on the HIV epidemic in Papua New Guinea: a country with extensive foreskin cutting practices.

Gray RT, Vallely A, Wilson DP, Kaldor J, MacLaren D, Kelly-Hanku A, Siba P, Murray JM; Male Circumcision Acceptability and Impact Study (MCAIS) team.

PLoS One. 2014 Aug 11;9(8):e104531. doi: 10.1371/journal.pone.0104531. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk